BioCentury
ARTICLE | Clinical News

Neurex regulatory update

July 1, 1996 7:00 AM UTC

NXCO filed an NDA for Corlopam (fenoldopam mesylate) for intravenous use in patients who require blood pressure control during and after surgery, as well as hypertensive patients for whom oral medica...